RA Capital Healthcare Fund LP's Form 4 filing
Bicara Therapeutics Inc. (BCAX) · filed Sep 18, 2024
- Accession no.
- 0001415889-24-023653
- Filed
- Sep 18, 2024, 6:02 PM ET
- Trade date
- Sep 16, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 4 derivative transactions. Open-market purchases total $33.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| RA Capital Healthcare Fund LPCIK 0001315082 | Director, 10% Owner |
| Ra Capital Management, L.P.CIK 0001346824 | Director, 10% Owner |
| Kolchinsky PeterCIK 0001384859 | Director, 10% Owner |
| Shah Rajeev M.CIK 0001619841 | Director, 10% Owner |
| RA Capital Nexus Fund III, L.P.CIK 0001883840 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2024 | Common Stock | CConversionAcquired | +2,622,898 | – | – | 2,622,898 | Indirect | |
| Sep 16, 2024 | Common Stock | CConversionAcquired | +2,500,095 | – | – | 2,500,095 | Indirect | |
| Sep 16, 2024 | Common Stock | PPurchaseAcquired | +1,680,520 | $18.00 | +$30,249,360 | 4,303,418 | Indirect | |
| Sep 16, 2024 | Common Stock | PPurchaseAcquired | +152,480 | $18.00 | +$2,744,640 | 2,652,575 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2024 | Common Stock | CConversionDisposed | −1,991,642 | – | – | 0 | Indirect | |
| Sep 16, 2024 | Common Stock | CConversionDisposed | −1,327,761 | – | – | 0 | Indirect | |
| Sep 16, 2024 | Common Stock | CConversionDisposed | −631,256 | – | – | 0 | Indirect | |
| Sep 16, 2024 | Common Stock | CConversionDisposed | −1,172,334 | – | – | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.